Evidence map›Paper›PMID 27186325›Full record

ArticleInternational journal of molecular epidemiology and genetics2016

GNAS gene mutation may be present only transiently during colorectal tumorigenesis.

Peter Zauber, Stephen P Marotta, Marlene Sabbath-Solitare

Open access · greenAbstract read
In one paragraph

Article in International journal of molecular epidemiology and genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Whole exome sequencing in relapsed or refractory childhood cancer: case series.Asian biomedicine : research, reviews and news · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. GPharmacological reviews · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Mutation Profiling of Premalignant Colorectal Neoplasia.Gastroenterology research and practice · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Peter ZauberDepartment of Medicine, Saint Barnabas Medical Center 100 Old Short Hills Road, Livingston, NJ 07039, USA.
Stephen P MarottaDepartment of Pathology, Saint Barnabas Medical Center 100 Old Short Hills Road, Livingston, NJ 07039, USA.
Marlene Sabbath-SolitareDepartment of Pathology, Saint Barnabas Medical Center 100 Old Short Hills Road, Livingston, NJ 07039, USA.
Saint Barnabas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations of the gene GNAS have been shown to activate the adenylate cyclase gene and lead to constitutive cAMP signaling. Several preliminary reports have suggested a role for GNAS gene mutations during colorectal carcinogenesis, particularly mucinous carcinomas. The aim of this study was to clarify the incidence of GNAS mutations in adenomas (tubular, tubulovillous, and villous), carcinomas with residual adenoma, and carcinomas, and to relate these findings to mutations of the KRAS gene and to the mucinous status of the tumors. We used standard PCR techniques and direct gene sequencing to evaluate tumors for gene mutations. No GNAS mutations were identified in 25 tubular adenomas, but were present in 6.4% of tubulovillous adenomas and 11.2% of villous adenomas. A GNAS mutation was found in 9.7% of the benign portion of carcinoma with residual adenoma, but in none of 86 carcinomas. A similar trend was seen for KRAS mutation across the five groups of tumors. GNAS mutations may function as an important driver mutation during certain phases of colorectal carcinogenesis, but may then be lost once the biological advantage gained by the mutated gene is no longer necessary to sustain or advance tumor development.

Indexed as

colon adenomascolon carcinogenesiscolon carcinomaGNAS gene mutationsmucinous carcinomas

Identifiers

PMID27186325
PMCPMC4858613
OpenAlexW2406413354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.